A detailed history of Bleichroeder LP transactions in Opti Nose, Inc. stock. As of the latest transaction made, Bleichroeder LP holds 4,045,132 shares of OPTN stock, worth $2.18 Million. This represents 0.92% of its overall portfolio holdings.

Number of Shares
4,045,132
Previous 4,045,132 -0.0%
Holding current value
$2.18 Million
Previous $4.21 Million 35.57%
% of portfolio
0.92%
Previous 1.52%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$1.68 - $3.7 $442,103 - $973,680
263,157 Added 6.96%
4,045,132 $7.48 Million
Q2 2022

Aug 10, 2022

BUY
$1.76 - $3.82 $70,023 - $151,982
39,786 Added 1.06%
3,781,975 $13.8 Million
Q1 2022

May 11, 2022

BUY
$1.77 - $2.93 $38,936 - $64,454
21,998 Added 0.59%
3,742,189 $9.24 Million
Q4 2021

Feb 10, 2022

BUY
$1.55 - $3.1 $5.77 Million - $11.5 Million
3,720,191 New
3,720,191 $6.03 Million

Others Institutions Holding OPTN

About OptiNose, Inc.


  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $45M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Bleichroeder LP Portfolio

Follow Bleichroeder LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bleichroeder LP, based on Form 13F filings with the SEC.

News

Stay updated on Bleichroeder LP with notifications on news.